baber/WOPTO huggingface dataset:
Patent NZ-332774-A (NZ)
Title: A method and a reactor for electrochemical conversion of a material e.g. soot particles being insoluble in a fluid
Inventor: CHRISTENSEN HENRIK
IPC: C25B1/00
Filed: 1997-05-20
Abstract: A method and a reactor are disclosed for electrochemical conversion of a material (21) being insoluble in a fluid into a material being soluble in the fluid, such that a flow of the fluid is passed to a reaction zone which comprises an internal circuit consisting of: one or more working electrodes (12), one or more counter-electrodes (13), and one or more ion-selective electrolytes (11), and which internal circuit is applied with an electrical voltage difference sufficient for the electrochemical processes; and use thereof for removal of soot particles from flue gasses and removal of oil in waste water.
Patent NZ-334075-A (NZ)
Title: Self-destructing document and e-mail messaging system
Inventor: UDELL HOWARD R
IPC: G06Q10/00
Filed: 1998-06-16
Abstract: A self-destructing document or e-mail messaging system is provided that automatically destroys documents or e-mail messages at a predetermined time by attaching a macro or virus to the document or e-mail message.  A macro is created 220 and is attached 230 to file such as an e-mail message 280 or document 270 when it is created.  The macro contains a portion of executable code or an executable program which instructs the computer to overwrite and/or delete the file to which the virus is attached at the predetermined time.
Patent NZ-337015-A (NZ)
Title: Measuring density of logs by striking log end and analysing resultant echos
Inventor: HARRIS PAUL DAVID
IPC: G01N3/30
Filed: 1999-07-30
Abstract: The density and other physical properties of logs are measured by striking the end of a log with a hammer 3.  A detector such as an accelerometer 1 is placed against the end of the log to measure the echo as the wave from the impact of the hammer are reflected from the sides and opposite end of the log.  The signal is analysed  mathematically to obtain a measure of the fundamental frequency fo of the log.  The length L of the log is measured separately and used in the process of calculating fo.  The analysis of the echo may involve testing all spectral peaks for membership to a series from which a best value of fo can be derived.  The fundamental frequency is related to the plane wave speed V and length L by    V = 2L/fo.  Noise spikes, peaks from unwanted modes, or other spurious signals are filtered using a comb filter.  The results of the measurement, together with a measure of the "goodness" of the measurements are displayed to the user.
Patent NZ-501162-A (NZ)
Title: Non-settling, universal machine dispensable pearlescent pigment dispersions comprising hydrous sodium lithium magnesium silicate in the liquid carrier
Inventor: BELLAS THOMAS M
IPC: C08K3/34
Filed: 1998-03-03
Abstract: An aqueous, non-settling, universal nacreous pigment dispersion that can be used in dispensing machines for the custom mixing of retail and trade sales of alkyd or solvent-thinned and water-based surface coatings employs a synthetic silicate, sodium lithium magnesium silicate, as the suspending agent. Also disclosed are methods for preparing the dispersion which incorporates one or more carriers, humectants, surfactants and other optional conventional additives.
Patent NZ-507873-A (NZ)
Title: Process for selective oxidation of primary alcohols
Inventor: BESEMER ARIE CORNELIS
IPC: C07B33/00
Filed: 1999-05-04
Abstract: A process for oxidizing primary alcohol using an oxidizing agent in the presence of a catalytic amount of di-tertiary-alkyl nitroxyl is described.  The oxidizing agent is a peracid or a precursor thereof, and the oxidation is carried out in the presence of 0.1-40 mol% of halide, with respect to the primary alcohol.
Patent NZ-510131-A (NZ)
Title: Apparatus for treating or killing animals
Inventor: LYNCH GRAHAM BRUCE
IPC: A01M23/12
Filed: 2001-02-23
Abstract: Disclosed is an apparatus (1) for the use in treating or killing animals. There is firstly a control means (2), a power source means such as solar panel (4) and an operation means for determining the duration of operation of the apparatus. There is also an animal sensing means (9), an animal attractant means and an animal treating or killing means. The apparatus is arranged to operate such that the operation means is activated to trigger the animal attractant means. When an animal comes within the operating zone, the sensing means will send an electronic signal to the control means to trigger the treatment or killing means.
Patent NZ-510317-A (NZ)
Title: Method of dewatering difficult sludges by administering an inorganic coagulant and a flocculant to the sludge
Inventor: SOMMESE ANTHONY G
IPC: C02F11/148
Filed: 1999-06-29
Abstract: A method for dewatering difficult sludges, such as autothermal thermophilic aerobic digestion sludges incorporates a three-component treatment system. Initially, the difficult sludge is dosed with an inorganic coagulant and then the resulting sludge - inorganic mixture is dosed with a microparticle component. Lastly, the resulting mixture is dosed with a flocculant.
Patent NZ-510620-A (NZ)
Title: Constant center of gravity tilt seat of a wheelchair
Inventor: MASCARI NICHOLAS A
IPC: A61G5/04
Filed: 1999-11-03
Abstract: A tilt seat (70) of a wheelchair (10) is operatively connected to a wheelchair frame through an archial support member (110) and through a gear rack (40) such that as the seat is tilted, the centre of gravity of a person seated in the wheelchair is substantially maintained.  A bracket (50), which slides along the gear rack (40), can be stopped at or released at any desired seat tilt inclination.  The wheelchair can also contain a reclinable seat back member (72), and marking elements, which show the tilt angle of the seat.
Patent NZ-512984-A (NZ)
Title: Compositions containing a water-soluble hydrocolloid, mucosal coat forming film useful for mucosal delivery
Inventor: CHEN LI-LAN H
IPC: A61P31/04
Filed: 1999-12-30
Abstract: A dosage unit comprising: a) an effective dose of sildenafil citrate, where it is formed in a solid dispersion with a water soluble inert filler. b) The solid dispersion is mixed with film forming reagents including a hydropolymer forming a film. The film is capable of dissolving on a mucosal surface releasing sildenafil. The film has the following characteristics: - dry tack value of less than 3.5g - a wet tack of greater than 35g - a gelation temperature that is greater than 70oC for a 2% polymer solution - a dry film thickness of not more than 20ml - water content of 0.5 to 10% - a tensile strength greater than 1500 psi - a tear propagation resistance of 0.001 to 1 N - a dissolution time of not more than 600 seconds upon application to an oral mucosal surface.
Patent NZ-515479-A (NZ)
Title: Cloning and expression of a novel 5-HT4 receptor
Inventor: BENDER ECKHARD
IPC: A61K48/00
Filed: 2000-06-14
Abstract: An isolated or substantially pure form of a nucleic acid molecule encoding a human 5-HT4(h) receptor comprising the amino acid sequence SEQ ID NO:2 or encoding a functional equivalent having more than 95% sequence identity to SEQ ID No:2 further characterised by an agonistic activity of the standard 5-HT4 receptor antagonist GR 113 808 on said functional equivalent. The agonist or antagonist may be used in the treatment of conditions which may include heartburn, Barrett's oesophagus. Oesophageal cancer, oesophageal hiatal hernia, asthma, denervation of the oesophagus and oesophageal stenosis.
Patent NZ-518862-A (NZ)
Title: Pharmaceutical formulations containing zolmitriptan
Inventor: DEARN ALAN ROY
IPC: A61K31/422
Filed: 2000-11-28
Abstract: A pharmaceutical formulation for intranasal administration, which comprises zolmitriptan and a pharmaceutically acceptable carrier wherein the pH of the formulation is below 6.0.
Patent NZ-523050-A (NZ)
Title: Combined marine and plant extract compositions
Inventor: OLSON BENGT KRISTER
IPC: A61K35/32
Filed: 2001-05-10
Abstract: A composition comprising cartilage extract, grape seed extract and tomato extract with anti-oxidant effect and free-radical inhibition. The composition which comprises a hydrophilic antioxidant, a lipophilic (hydrophobic) antioxidant, and a cartilage extract increases collagen synthesis in the dermis. Furthermore, the composition lowers collagenase activity and levels of advanced glycation end products (AGE). The signs of ageing, such as photoageing due to exposure to UV radiation, are related to the levels of collagen syntheses and free-radical oxidation. Compositions of the invention are intended for the treatment of ageing skin and the delaying of the onset of the signs of ageing in healthy skin.
Patent NZ-531986-A (NZ)
Title: Salt-inducible or salt-responsive proteins selected from ESI3, CSA, LT16, SALT, WESR5 and ALDP from ryegrass (Lollum) or fescue (Festuca)
Inventor: SPANGENBERG GERMAN
IPC: C12N9/08
Filed: 2002-10-04
Abstract: A substantially purified or isolated nucleic acid encoding a glutathione peroxidase homolog (CSA) and its polypeptide from a ryegrass (Lolium) species are described. Vectors and plant cells comprising the nucleic acid are described. The nucleic acid can be introduced into a plant to modify plant tolerance to environmental and/or osmotic stress, to modify a plants capacity to survive salt shock, to modify compartmentalization of sodium in a plant, to modify sodium ion influx or efflux, to modify plant recovery after exposure to salt stress, to modify plat metabolism under salt stress, or can be used as a molecular marker.
Patent NZ-533037-A (NZ)
Title: Photodynamic therapy for the treatment of hair loss
Inventor: SIMKIN GUILLERMO O
IPC: A61K41/00
Filed: 2002-11-08
Abstract: Disclosed is a method of treating skin tissue exhibiting, or suspected of, hair growth reduction or hair loss comprising: Administering to said skin tissue an effective amount of a BPD or green porphyrin photosensitizer capable of penetrating in to the tissue to result in a desired degree of biodistibution; and Irradiating the skin with light containing a wavelength of about 400 to about 900nm and absorbed by said BPD or green porphyrin photosensitizer. In particular the above method may be used for treating hair loss due to androgenetic alopecia, alopecia areata, drug induced alopecia, or radiation induced alopecia.
Patent NZ-535066-A (NZ)
Title: Packaging films having microporous and oxygen impremeable layers and methods for producing the same
Inventor: MOEHLENBROCK ANDREW W
IPC: B32B7/02
Filed: 2004-09-02
Abstract: A multilayer film that is suitable for packaging oxygen-sensitive food products such as meat, dairy products, fruits and cut vegetables and a process for manufacturing the multilayer film is disclosed, wherein the film comprises: a first outer layer; a second outer layer; and at least one intermediate microporous polymer layer disposed between the first and the second outer layers, wherein the first and second outer layers are independently formed from heat sealable polymer compositions and wherein the intermediate layer is formed from an unfilled (without fillers) oxygen impermeable polymer composition.
Patent NZ-537398-A (NZ)
Title: Method of freezing meat in a marinade
Inventor: LIBERMAN BARNET L
IPC: A23L13/00
Filed: 2003-07-01
Abstract: A method of freezing meat in a marinade comprises placing meat and a marinade in a bag which can be vacuum sealed, vacuum sealing the meat and marinade in the bag without allowing any substantial time for marination, preparing a brine solution containing between 0.05% and 1.0% by weight of cruciferous oil, and freezing the meat by immersing the vacuum sealed bag in the brine solution at a temperature about -22 and -43.6oF, whereby the meat can be properly marinated in the same amount of time as fresh meat placed in the marinade.
Patent NZ-542993-A (NZ)
Title: Bone fixation apparatus with flexible connecting members insertable into passages of bone fixation elements
Inventor: FRIGG ROBERT
Filed: 2003-04-15
Abstract: The apparatus is used for bone fixation, particularly during vertebral surgery, and includes at least two bone fixation elements (2) both having a part (3), which can be anchored on or in the bone, and having a passage (4). The apparatus includes at least two longitudinal and flexible joining elements (5), which can be inserted into the passages (4) of both adjacent bone fixation elements (2) and secured therein. The apparatus is stated to permit a large degree of flexibility with regard to anatomical relationships, and to the surgically achieved results during the implantation of the apparatus, and permits a complete staying by means of a simple blocking of the elements of the apparatus that can move relative to one another. In addition, the apparatus enables a minimally invasive treatment of the vertebral column.
Patent NZ-548169-A (NZ)
Title: Piperazines useful for treating pain
Inventor: SUN QUN
IPC: C07D213/74
Filed: 2004-12-17
Abstract: Disclosed is a compound of Formula (I), or a pharmaceutically acceptible salt thereof, where Ar1 is a nitrogen-containing aromatic ring, and the other substituents are as disclosed in the specification. Also disclosed is the use of the compound for treating pain, urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, or any condition requiring inhibiting VR1 function in a cell
Patent NZ-549971-A (NZ)
Title: Methods for the preparation of (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol
Inventor: LOMMEN FRANCISCUS ALPHONS MARIE
IPC: C07D307/20
Filed: 2005-03-31
Abstract: Disclosed is a method for the synthesis of (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol having the structure of formula (6), which method comprises the use of the intermediate of formula alpha -(4).
Patent NZ-550436-A (NZ)
Title: Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
Inventor: HORVATH STEPHANE
Filed: 2006-10-10
Abstract: A process for the preparation of the delta-d-crystalline form of ivabradine hydrochloride of formula (I) is disclosed, wherein acetonitrile or a mixture of acetonitrile and water is preheated, ivabradine hydrochloride is added, the solution obtained is allowed to cool at room temperature, held at room temperature until crystallisation is complete, and the crystals formed are dehydrated. This delta-d-crystalline form of ivabradine hydrochloride is suitable as a bradycardic and is used in the manufacture of medicaments which are of use in the treatment or prevention of various clinical situations of myocardial ischaemia such as angina pectoris, myocardial infarct and associated rhythm disturbances, and also in various pathologies involving rhythm disturbances, especially supraventricular rhythm disturbances, and in heart failure.
Patent NZ-563546-A (NZ)
Title: A portable system for reconditioning used barrels
Inventor: WATERMAN BRECK
Filed: 2007-11-21
Abstract: A mobile system for reconditioning used barrels is disclosed. The system includes a portable shaving apparatus 32 having a scanning means 34. The scanning means are adapted to scan the dimensions of the internal surface of the used barrel relative to a fixed point. A cutting means is adapted to uniformly shave the internal surface to a predetermined depth relative to the scanned internal dimensions. A portable toasting apparatus reconditions the shaved internal surface so that is ready for re-use. A portable means of re-crozing at least one end of the barrel, the means including an annular support configured to rest on top of the barrel during use, and a cutting means configured to rotate relative to the annular support and thereby form a groove along the inside surface of the barrel adjacent to at least one end. The groove is adapted to accommodate a barrel head.
Patent NZ-564244-A (NZ)
Title: Venting container
Inventor: MAXWELL JASON R
IPC: B65D41/18
Filed: 2006-06-05
Abstract: A venting container including a lid and base having an inner cavity and a side wall that terminates in a rim, the lid including a central panel and a peripheral sealing lip that surrounds the panel, the peripheral sealing lip having a generally inverted U-shaped cross section that defines a lid channel into which the container rim fits, the sealing lip including at least one venting feature in the form of a flexible venting button that is adapted to transition from a first position to a second position upon application of an actuation force, the venting button being further adapted and positioned whereby when the container rim is positioned in the lid channel and the venting button is in the first position, sealed engagement of the lid to the container is effectuated and when the venting button is in the second position a venting air passage is provided from the container cavity to the container surroundings. In a second embodiment, the venting feature is in the form of a downwardly protruding venting boss provided to the lid closure and a boss seat formed in the base closure whereby the venting boss is received with the boss seat when the lid is oriented in a first non venting attachment position and the venting boss abuts against a surface of the base closure to provide a vent passage between the lid and base upon removal and repositioning of the lid to a second venting attachment position.
Patent NZ-570600-A (NZ)
Title: M-commerce virtual cash system, method, and apparatus
Inventor: WALTMAN JOAN T
IPC: G06Q20/00
Filed: 2007-03-15
Abstract: A method for operating a virtual cash system over a wireless communication network, implemented by an apparatus, is disclosed. The method comprises: (a) wirelessly receiving at a wireless device available cash information transmitted over the wireless communication network and corresponding to an amount of money deposited in an account record associated with the wireless device, to enable a user determined portion of the amount of money to be spent directly from the wireless device as cash in a transaction; (b) generating an indicator of the available cash information and the account record by the wireless device; (c) providing the indicator to a merchant's device to enable the account record to be identified and debited for the user determined portion of the amount of money; and (d) wirelessly receiving at the wireless device, an updated available cash information transmitted over the wireless communication network and comprising a new available cash amount after a debiting of the account record for the transaction.
Patent NZ-573704-A (NZ)
Title: Joint compound container with a scraping edge
Inventor: BRUNO ROBERT H
IPC: B65D25/00
Filed: 2007-05-21
Abstract: A joint compound container is disclosed and which includes a trough shaped body and a reinforcing band that forms a scraping edge. The body is formed from two opposing end walls affixed to the body and two planar sidewalls separated from one another by a planar floor. Each of the sidewalls shares a respective common radiussed edge with the floor. The reinforcing band is attached to the exterior of the body as a separate component and is configured to reinforce each of the sidewalls and the end walls. The band is displaced from the upper edge of the joint compound container by a distance, which is sufficient to define a scraping edge.
Patent NZ-577393-A (NZ)
Title: Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
Inventor: TUITEN JAN JOHAN ADRIAAN
IPC: A61K31/496
Filed: 2007-11-02
Abstract: Disclosed is the use of 3-alpha-androstanediol and a type 5 phosphodiesterase (PDE5) inhibitor in the preparation of a medicament for the on demand treatment of sexual dysfunction, wherein said 3-alpha-androstanediol and said PDE5 inhibitor are released at essentially the same time so that their peak effects at least partially coincide.
Patent NZ-582057-A (NZ)
Title: 5-membered heterocyclic amides and related compounds
Inventor: LI HONGBIN
IPC: C07D417/12
Filed: 2008-07-21
Abstract: Disclosed is a compound of the formula I or a pharmaceutically acceptable salt or hydrate thereof, e.g. 1-(4-Amino-5-fluoropyrimidin-2-yl)-N-((1-(pyridin-3-yl)cyclohexyl)methyl)-3- (trifluoromethyl)-1H-pyrazole-4-carboxamide wherein Z represents pyrazole, thiazole, imidazole, oxazole or thiophene and the other substituents are defined in the specification for treating pain, osteoarthritis, rheumatoid arthritis, arthrosclerosis, glaucoma, irritable bowel syndrome, inflammatory bowel disease, cirrhosis, lupus, scleroderma, Alzheimer's disease, traumatic brain injury, asthma, chronic obstructive pulmonary disease, or interstitial fibrosis.
Patent NZ-585520-A (NZ)
Title: A coupling assembly having a base, a collar, an expansion causing member, and an actuator
Inventor: ASQUITH WARREN HAYDEN
IPC: F16B12/06
Filed: 2010-05-21
Abstract: A coupling to secure a first member to a second member is disclosed. The first member is hollow so as to have an internal chamber, and an opening providing access to the chamber. The coupling includes a base, a collar, an expansion causing member, and an actuator. The base is fixed to the first member and has a socket within which the second member is received. The base further includes a stem to be secured within the chamber by being inserted through the opening. The collar surrounds the stem and is located in the chamber so as to be positioned between the first member and the stem. The expansion causing member engages with the stem so as to be movable relative thereto, and to engage the collar. The actuator extends between the base and the expansion causing member to cause movement of the expansion causing member in a predetermined direction to cause outward expansion of the collar to engage the first member to secure the coupling to the first member.
Patent NZ-589513-A (NZ)
Title: Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
Inventor: BRIAULT GILES
IPC: A61K33/24
Filed: 2010-11-24
Abstract: Disclosed is a pharmaceutical composition comprising a strontium salt, vitamin D, a cyclodextrin and also one or more other inert, nontoxic, pharmaceutically acceptable excipients or carriers wherein the weight ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800. The pharmaceutical composition is used to treat bone diseases or arthrosis.
Patent NZ-591001-A (NZ)
Title: Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
Inventor: JONES ROBERT M
IPC: A61K31/407
Filed: 2009-08-26
Abstract: Disclosed are substituted tricyclic acid derivatives of Formula (I), salts and solvates thereof, and methods for their preparation. Specific examples of compounds of Formula (I) include: (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-9-methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acid, (R)-2-(7-(3-cyano-4-isopropoxybenzyloxy)-9-methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acid, and 2-(9-chloro-7-(4-(cyclopropylmethoxy)-3-(trifluoromethyl)benzyloxy)-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acid. Compounds of Formula (I) are agonists of the sphingosine-1-phosphate receptor 1 (S1P1 receptor) and are useful in the treatment of S1P1-associated disorders such as psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, myocardial ischemia-reperfusion injury injury, hypertensive nephropathy, glomerulosclerosis, gastritis, polymyositis, thyroiditis, vitiligo, hepatitis, biliary cirrhosis, microbial infections and associated diseases, viral infections and associated diseases, diseases and disorders mediated by lymphocytes, auto immune diseases, inflammatory diseases, and cancer.